AusPAR: Atazanavir

Australian Public Assessment Report

AusPAR

AusPAR: Atazanavir [PDF, 833.63 KB]

AusPAR: Atazanavir [Word, 1.54 MB]

Attachment: Product Information: Atazanavir [PDF, 644.28 KB]

Attachment: Product Information: Atazanavir [Word, 654 KB]

Attachment: Extract from Clinical Evaluation Report: Atazanavir [PDF, 2.03 MB]

Attachment: Extract from Clinical Evaluation Report: Atazanavir [Word, 3.6 MB]

Device/Product Name

Reyataz

Active ingredients

Atazanavir

AusPAR Date

21 October 2013

Published

20 November 2013

Submission Number

PM-2012-01034-3-2

Submission Type

Major variation (change in paediatric dosage regimen, PI updates)

Decision

Approved